ReviewClinical, cosmetic and investigational dermatology2026
Facial Overfilled Syndrome: A Narrative Clinical Review.
Review in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Facial Overfilled Syndrome (FOS) is an increasingly prevalent iatrogenic complication resulting from the excessive or inappropriate use of dermal fillers. Clinically significant for causing facial distortion and unnatural dynamics, it is frequently compounded by profound psychological distress and aesthetic perception biases. Aim: This narrative clinical review aims to summarize the etiology, clinical features, diagnostic approaches, and management strategies of FOS, establishing a structured framework to emphasize the importance of prevention through anatomical knowledge and individualized treatment planning. Methods: A comprehensive literature search was conducted in PubMed, Google Scholar, and CNKI using keywords such as "facial overfilled syndrome", "facial overfilling", "overfilled face" and "dermal filler complications". Relevant original studies, clinical trials, meta-analyses, and reviews published until October 2025 were included and synthesized into a narrative framework. Results: The pathogenesis of FOS extends beyond mere volumetric excess, driven by a complex triad of anatomical mismatch, biomechanical dysregulation, and the cumulative payload of repeated treatments. Clinical hallmarks include resting distortion and unnatural facial animation. Management must be highly individualized; while targeted, ultrasound-guided hyaluronidase injection remains the established gold standard for hyaluronic acid fillers, evolving adjunctive therapies (eg, recombinant enzymes, energy-based devices, and micro-liposuction) demand strict clinical caution. Conclusion: Addressing FOS requires a clinical paradigm shift from simple volume restoration to precision-driven, layer-specific augmentation. Prevention through patient education and anatomical mastery is paramount. Future research should prioritize elucidating filler degradation kinetics, developing objective 3D assessment tools, and engineering fully reversible biomaterials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.